3 Results for "

Polθ-pol

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Polθ-pol" in MCE Product Catalog:

Cat. No.: HY-161430
CAS No.: 3035072-49-9
Research Areas:  

Cancer

RTx-161 is a DNA polymerase θ inhibitor with an IC50 of 4.1 nM. RTx-161 induces DNA damage, PARP cleavage, apoptosis, and selectively kills homologous recombination-deficient (HRD) cells. RTx-161 acts synergistically with PARP inhibitors to suppress PARP inhibitor resistance in cancer cells. RTx-161 can be used for the research of BRCA G12C mutant cancer and HR-deficient cancers .
loading...
    loading...
Cat. No.: HY-161431
CAS No.: 3035072-48-8
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

RTx-152 traps Polθ on DNA and is an allosteric Polθ-pol inhibitor (IC50: 6.2 nM). RTx-152 selectively kills HR-deficient cancer cells, and suppresses PARP inhibitor resistance in multiple genetic backgrounds, including homologous recombination (HR)-proficient cells. RTx-152 selectively kills BRCA2-null cells .
loading...
    loading...
Cat. No.: HY-181611
CAS No.: 3068829-46-6
Research Areas:  

Cancer

Polθ-IN-10 is an orally active Polθ-pol inhibitor (with a human IC50 of 1.3 nM) that exhibits oral bioavailability in mice and rats. Polθ-IN-10 binds to the allosteric site of Polθ-pol, disrupts the microhomology-mediated end-joining DNA repair pathway, and inhibits CYP2C9 (IC50=1.63 μM). Polθ-IN-10 selectively inhibits the proliferation of HR-deficient cancer cells and induces apoptosis. Polθ-IN-10 is applicable to the research of HR-deficient cancers .
loading...
    loading...